PT Indofarma Tbk reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was IDR 574,053.82 million compared to IDR 849,325.49 million a year ago. Net loss was IDR 90,715.02 million compared to net income of IDR 977.78 million a year ago.

Basic loss per share from continuing operations was IDR 29.27 compared to basic earnings per share from continuing operations of IDR 0.32 a year ago.